Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from Jatropha cordata bark have significant anti-inflammatory effects and could help with hair loss.

Essential oils from Curcuma species, like turmeric, have compounds that can fight inflammation, cancer, and bacteria, and can also stimulate hair regrowth in bald males.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Eclipta alba has many health benefits and potential for medical and nutritional use.

Vitamin D is important for skin health and can affect various skin diseases.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Cetuximab can cause excessive eyelash growth.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The combination treatment showed a higher response rate but no significant survival benefits.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.